Compare Edwards Lifesciences Corporation Common Stock (EW) vs J M Smucker Co (SJM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs J M Smucker Co — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $49.44B), while J M Smucker Co trades at $120.56 (market cap $12.38B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 4× J M Smucker Co's market cap, and J M Smucker Co pays a 3.86% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | SJM | |
|---|---|---|
Market Cap | $49.44B | $12.38B |
Volume | 3,508,027 | 1,013,558 |
Sector | Health | Consumer Staples |
52-Week High | $95.18 | $132.34 |
52-Week Low | $72.65 | $89.53 |
Enterprise Value | $45.90B | $19.24B |
Typical Hold Time | — | 74 Days |
Dividend Yield | — | 3.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SJM trades at $119.41, up 2.23% today, with a bearish technical signal but strong recent earnings beats. The company reported a net loss of $1.23 billion in 2025 despite revenue growth to $8.73 billion, though analysts project a return to profitability in 2026. A dividend of $1.12 is scheduled for September 2026, and institutional interest is rising, as seen with CalSTRS increasing its stake significantly in Q2 2026.
The outlook is mixed: analyst consensus is bullish with a $137.29 price target, but high debt and volatile profitability pose risks. Earnings momentum from recent beats and raised 2027 guidance support upside, yet investors must weigh margin pressures and competitive threats in the consumer staples sector against growth in segments like Uncrustables and Cafe Bustelo.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About J M Smucker Co
J.M. Smucker is a packaged food company that primarily operates in the U.S. retail channel (87% of fiscal 2022 revenue), but also in U.S. food-service (7%), and international (6%). Its largest segment is pet food and treats (36% of 2022 revenue), with popular brands such as Milk-Bone, Meow Mix, 9Lives, Kibbles 'n Bits, Nature's Recipe, and Rachael Ray Nutrish. Its second-largest category is coffee (35% across channels) with the number-two brand Folgers and number-six Dunkin'. Other large categories are peanut butter (10%), with number-one Jif, fruit spreads (5%) with number-one Smucker's, and frozen hand-held foods (6%) with number-one Uncrustables.
Read more on SJM →
